Effect of multiple sclerosis disease-modifying therapies on the real-world effectiveness of two doses of BBIBP-CorV (Sinopharm) vaccine

BACKGROUND: Immunogenicity data shows blunted responses to COVID-19 vaccination among people with MS (pwMS) on certain disease-modifying therapies (DMTs). Still, it is uncertain how this data translates into the clinic. OBJECTIVE: To assess the effect of DMTs and other factors on the effectiveness o...

Descripción completa

Detalles Bibliográficos
Autores principales: Etemadifar, Masoud, Abhari, Amir Parsa, Nouri, Hosein, Eighani, Naghme, Salari, Mehri, Sedaghat, Nahad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Clinical Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731817/
https://www.ncbi.nlm.nih.gov/pubmed/36521195
http://dx.doi.org/10.1016/j.jns.2022.120518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731817/
https://www.ncbi.nlm.nih.gov/pubmed/36521195
http://dx.doi.org/10.1016/j.jns.2022.120518

Ejemplares similares